author-photo

David B. Ring

Chiron Corporation

23

Papers

981

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Discovery and Optimization of Novel Pyridines as Highly Potent and Selective Glycogen Synthase Kinase 3 Inhibitors

2019 ChemRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.

2017 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (15)
Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats

2003 American Journal of Physiology-endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (100)
Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo

2003 Diabetes
Show All
- Source
- Cite
- Save
Citations (375)
Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment.

1997 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (19)
Murine bispecific antibody 1A10 directed to human transferrin receptor and a 42-kDa tumor-associated glycoprotein.

1996 Clinical Immunology and Immunopathology
Show All
- Source
- Cite
- Save
Citations (1)
In VitroTumor Growth Inhibition by Bispecific Antibodies to Human Transferrin Receptor and Tumor-Associated Antigens Is Augmented by the Iron Chelator Deferoxamine

1996 Clinical Immunology and Immunopathology
Show All
- Source
- Cite
- Save
Citations (12)
Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor

1996 Cancer Research
Show All
- Source
- Cite
- Save
Citations (5)
Human neutrophil interactions of a bispecific monoclonal antibody targeting tumor and human Fcγ RIII

1996 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (22)
Clinical Development of 2B1, a Bispecific Murine Monoclonal Antibody Targeting c-erbB-2 and FcγRIII

1995 Journal of hematotherapy
Show All
- Source
- Cite
- Save
Citations (54)